OncoMed Pharmaceuticals Secures $40,000,000 New Financing Round

  • Feed Type
  • Date
  • Company Name
    OncoMed Pharmaceuticals
  • Mailing Address
    800 Chesapeake Drive Redwood City, CA 94063
  • Company Description
    OncoMed Pharmaceuticals is discovering and developing monoclonal antibodies and small molecules capable of destroying “cancer stem cells”, a recently discovered type of cell believed to seed the growth of cancers and underlie cancer’s ability to spread and take root in tissues.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The deal will provide OncoMed with $40 million in upfront cash, and also could offer milestone payments for as many as five different drug candidates, which have potential to generate as much as $387 million in milestone payments each for OncoMed.
  • M&A Terms
  • Venture Investor

Trending on Xconomy